NCT06164977

Brief Summary

Aim of the study is to evaluate chronic total coronary occlusion treatment results 6 years after bioresorbable scaffold implantation by quantitative coronary analysis, intravascular ultrasound and optical coherence tomography.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2017

Completed
6.8 years until next milestone

First Submitted

Initial submission to the registry

November 22, 2023

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 11, 2023

Completed
Last Updated

June 11, 2025

Status Verified

June 1, 2025

Enrollment Period

6.8 years

First QC Date

November 22, 2023

Last Update Submit

June 6, 2025

Conditions

Keywords

AtherosclerosisChronic total coronary occlusionIntravascular ultrasoundOptic coherence tomography

Outcome Measures

Primary Outcomes (1)

  • Target Lesion Failure

    Target Lesion Failure (TLF) will be assessed as the number of participants experiencing at least one of the following events during the follow-up period: cardiovascular death, clinically driven target lesion revascularization, target vessel myocardial infarction and stent thrombosis according to the Academic Research Consortium.

    6 years

Study Arms (1)

Chronic total coronary occlusion

OTHER

Participants who underwent percutaneous coronary intervention for chronic total coronary occlusion revascularization with bioresorbable scaffold.

Procedure: Percutaneous coronary intervention.

Interventions

Revascularization of chronic total coronary occlusion.

Chronic total coronary occlusion

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • % occlusion of a coronary artery for a duration of greater than or equal to 3 months based on angiographic evidence.

You may not qualify if:

  • Participant withdrawal from study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pauls Stradins Clinical University Hospital

Riga, Rīga, LV-1002, Latvia

Location

MeSH Terms

Conditions

Angina PectorisCoronary Artery DiseaseCoronary OcclusionAtherosclerosis

Interventions

Percutaneous Coronary Intervention

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCoronary DiseaseArteriosclerosisArterial Occlusive Diseases

Intervention Hierarchy (Ancestors)

Endovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single group consists of study participants who where treated for chronic total coronary occlusion with bioresorbable scaffolds
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2023

First Posted

December 11, 2023

Study Start

February 1, 2017

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

June 11, 2025

Record last verified: 2025-06

Locations